The Summit of Science.
The Peak of Care.

Mount Clinical Research accelerates medical innovation from bench to bedside - a physician-led, multi-specialty CRO with an in-house bioanalytical laboratory and AI-powered analysis through FlowAutoGate™.

9
Physician & scientist leaders
9
Therapeutic focus areas
70%
Faster data turnaround
Scientist inspecting a sample vial in the laboratory
Scientist examining samples through a microscope
MCRMCRMCR

Accelerated
Medical
Innovation

Trusted partners

  • Rio Eigen AI
  • Helixbridge
  • Northpeak Bio
  • Cortiva Labs
  • Aetherion
  • Meridian Immuno
  • Cascade CRO
  • Vantage Trial

What we do

Full-service clinical research, built around physician judgment

Preclinical Research Services

Preclinical Research Services

Feasibility, protocol consultation, and translational support that bridges bench science to first-in-human readiness.

Learn more

Therapeutic focus

Full-service clinical research, built
around physician judgment

Nine therapeutic areas, anchored by three primary focus areas

  • Pain Medicine &
    Neuromodulation

    Comprehensive capabilities for device and pharmaceutical trials targeting chronic pain, with expertise in spinal cord stimulation, peripheral nerve stimulation, and intrathecal drug delivery.

    Read more
  • Psychiatry & Central
    Nervous System

    Specialized infrastructure for psychiatric clinical trials including psychedelic-assisted therapy, treatment-resistant depression, and digital therapeutics, including an active DEA Schedule I researcher license.

    Read more
  • Vaccines &
    Immunology

    Comprehensive immunogenicity assessment for vaccine and immunotherapy trials - our core differentiator, enabling rapid biomarker turnaround with full chain-of-custody control.

    Read more
  • Wound Care &
    Diabetic Complications

    Targeting the $15 billion chronic wound market with expertise in advanced wound technologies, diabetic complication management, and cellular/tissue-based therapies.

    Read more
  • Neurology

    Neurological device trials, neurodegenerative disease studies, and headache/migraine programs supported by dual neurosurgery and neuromodulation expertise.

    Read more
  • Metabolic &
    Cardiometabolic Disease

    Integrated metabolic disease trial services spanning obesity, type 2 diabetes, NASH/MASH, and dyslipidemia.

    Read more
  • Cardiovascular &
    Heart Failure

    Rigorous cardiovascular and heart failure trials with a focus on self-management interventions, digital therapeutics, and care transitions.

    Read more
  • Geriatrics, Aging &
    Care Transitions

    Studies targeting multimorbidity, polypharmacy optimization, frailty, and hospital-to-home transitions for older adults.

    Read more
  • Health Equity &
    Disparities Research

    Chicago's diverse metropolitan population and our team's cultural competency enable trials that meaningfully address health disparities and FDA diversity requirements.

    Read more

AI Solutions

FlowAutoGate™:
automated flow cytometry,
built for audit-ready trials

Developed with Rio Eigen AI, FlowAutoGate™ gates complex immunology panels in seconds - with a complete 21 CFR Part 11 audit trail attached to every result.

FlowAutoGate automated flow cytometry analysis on a lab workstation with an immunologist reviewing gating results

Our advantage

Science and enrollment,
without the hand-offs

  • In-House Bioanalytical Laboratory

    Flow cytometry, ELISpot/FluoroSpot, ELISA, cytokine bead array, and PBMC processing under one roof - eliminating third-party shipping delays and giving sponsors same-week immunogenicity turnaround.

    See lab capabilities
    Scientist carefully pipetting a sample into a test tube in the laboratory
  • Diverse, Chicago-Based Enrollment

    A demographically diverse metro population, multilingual coordinators, and community partnerships built to meet FDA diversity action plan expectations — not just check a box.

    For patients & participants
    Diverse group of young people smiling outdoors
Dr. Ikechukwu Okafo, MD, MBA

Dr. Ikechukwu Okafo, MD, MBA

CEO & Principal Investigator

|

Resource Hub

Explore more research notes, white papers & case studies

View all resources
Building an AI-Native Research Site From the First Patient Onward
White Paper

Building an AI-Native Research Site From the First Patient Onward

Why sites built around AI from day one — rather than retrofitting legacy systems — hold a structural advantage sponsors are beginning to score for.

Read more

Partner with us

Let's design your next study for both speed and rigor.

Whether you need a full-service site, in-house bioanalytical support, or a FlowAutoGate™ pilot, our team can typically turn around a feasibility response within 5 business days.

Research scientist analyzing blood samples under a microscope in the laboratory